Archives for August 27, 2007

← 2007

First US cell-based flu vaccine plant underway

By  Anna Lewcock

Novartis last week began construction of a major new flu vaccine manufacturing facility in North Carolina, the very first cell culture-derived flu vaccine plant in the United States.

Measuring bioprocess shear stress

By  Dr Matt Wilkinson

A new device has been developed enabling researchers to study the stability of therapeutic proteins against shear stresses to allow better bioprocess optimisation.

Nicholas Piramal to spin off R&D unit

By  Emilie Reymond

Nicholas Piramal is the latest Indian pharma firm planning to spin off its new chemical entity (NCE) research unit as its pipeline is maturing.

Billionaire to get bigger Biogen stake?

By  Emilie Reymond

Investment mogul Carl Icahn could get ready to buy further shares of biotech company Biogen Idec after getting the green light from the competition regulators.

R&D news in brief

By  Mike Nagle

In a round up of the latest news in pharma research, Pfizer and Bristol-Myers Squibb have big plans for DGAT-1 in obesity and diabetes, GlaxoSmithKline is extra keen on Exelixis' anticancer drug, Takeda is talking TLRs and UK scientists have made 'a...